AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

MAYNE PHARMA GROUP LTD

3.025

+0.1856.51%

Volume:513.18K

Turnover:1.50M

Market Cap:245.77M

PE:-2.55

High:3.030

Open:2.920

Low:2.850

Close:2.840

52wk High:7.310

52wk Low:2.600

Shares:81.25M

Float Shares:67.00M

Volume Ratio:1.99

T/O Rate:0.77%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.188

EPS(LYR):-1.186

ROE:-21.85%

ROA:-1.28%

PB:0.66

PE(LYR):-2.55

Loading ...

Overview Company News Filings

Concept

Pharmaceutical Companies-5.49%

Capital Flow

Inflow:

Outflow:

News

Mayne Pharma Group Says Fiscal 2026 H1 Unaudited Revenue Falls 0.5% Year on Year

MT Newswires Live

BRIEF-Mayne Pharma Posts FY A$47M Underlying EBITDA

Mayne Pharma Group Ltd - FY Reported Revenue a$408.1 Mln

THOMSON REUTERS

Mayne Pharma Group Ltd - FY a$47M Underlying Ebitda

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/MYX.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MYX.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"MYX.AU\",,,,,undefined,":{"symbol":"MYX.AU","market":"AU","secType":"STK","nameCN":"MAYNE PHARMA GROUP LTD","latestPrice":3.025,"timestamp":1770782351473,"preClose":2.84,"halted":0,"volume":513177,"delay":0,"changeRate":0.06514084507042256,"nameEN":"MAYNE PHARMA GROUP LTD","floatShares":66997185,"shares":81245827,"eps":-1.187574,"marketStatus":"Trading","change":0.185,"latestTime":"02-11 14:59:43 AEDT","open":2.92,"high":3.03,"low":2.85,"amount":1503759,"amplitude":0.06338,"askPrice":3.03,"askSize":1589,"bidPrice":3.02,"bidSize":3007,"shortable":3,"etf":0,"ttmEps":-1.187574,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1770786000000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":2.84,"openAndCloseTimeList":[[1770764400000,1770786000000]],"volumeRatio":1.993546,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"MYX.AU\",,,,,undefined,":{"symbol":"MYX.AU","floatShares":66997185,"roa":"-1.28%","roe":"-21.85%","lyrEps":-1.185711,"volumeRatio":1.993546,"shares":81245827,"dividePrice":0,"high":3.03,"amplitude":0.06338,"preClose":2.84,"low":2.85,"week52Low":2.6,"pbRate":"0.66","psRate":"0.60","week52High":7.31,"institutionHeld":0,"latestPrice":3.025,"committee":0.308529,"eps":-1.187574,"divideRate":0,"volume":513177,"delay":0,"ttmEps":-1.187574,"open":2.92,"prevYearClose":3.11,"prevWeekClose":2.63,"prevMonthClose":2.8,"prevQuarterClose":3.11,"fiveDayClose":2.73,"twentyDayClose":3.01,"sixtyDayClose":4.85,"dividendPayoutRate":0.04569711225089115,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0.014818181818181815},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MYX.AU\",params:#limit:5,,,undefined,":[{"date":"2025-08-29","symbol":"MYX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756425600000,"name":null,"time":"","dateTimestamp":1756389600000,"actualEps":null},{"date":"2025-02-26","symbol":"MYX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1740524400000,"name":null,"time":"","dateTimestamp":1740488400000,"actualEps":null},{"date":"2024-08-23","symbol":"MYX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724371200000,"name":null,"time":"","dateTimestamp":1724335200000,"actualEps":null},{"date":"2024-02-26","symbol":"MYX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1708902000000,"name":null,"time":"","dateTimestamp":1708866000000,"actualEps":null},{"date":"2023-08-31","symbol":"MYX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1693440000000,"name":null,"time":"","dateTimestamp":1693404000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MYX.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2023-01-18","recordDate":"2023-01-19","paymentDate":"2023-01-27","value":0.038,"currency":"AUD"}],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MYX.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2607779014","title":"Mayne Pharma Group Says Fiscal 2026 H1 Unaudited Revenue Falls 0.5% Year on Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2607779014","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607779014?lang=en_us&edition=fundamental","pubTime":"2026-01-29 12:03","pubTimestamp":1769659432,"startTime":"0","endTime":"0","summary":"Mayne Pharma Group  said its unaudited revenue for the fiscal 2026 first half came in at AU$212.1 million, down 0.5% from the result it reported in the year-ago period, according to a Thursday Australian bourse filing.Its unaudited underlying earnings before interest, taxes, depreciation, and amortization  for the period clocked in at AU$28.6 million, down 8% year-over-year from AU$31 million in the first half of fiscal year 2025.It cited a lower contribution from the women's health segment, as well as additional investment into sales activities, as drivers behind the underlying EBIDTA.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7096","BK7508","MYX.AU"],"gpt_icon":0},{"id":"2607206547","title":"BRIEF-Mayne Pharma Posts FY A$47M Underlying EBITDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2607206547","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607206547?lang=en_us&edition=fundamental","pubTime":"2026-01-29 09:22","pubTimestamp":1769649758,"startTime":"0","endTime":"0","summary":"BRIEF-Mayne Pharma Posts FY A$47M Underlying EBITDAJan 29 (Reuters) - Mayne Pharma Group Ltd MYX.AX:FY REPORTED REVENUE A$408.1 MILLIONFY A$47M UNDERLYING EBITDAFurther company coverage: MYX.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260129:nFWN3YT1CL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7096","MYX.AU"],"gpt_icon":0},{"id":"2607729858","title":"Mayne Pharma Group Ltd - FY Reported Revenue a$408.1 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2607729858","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607729858?lang=en_us&edition=fundamental","pubTime":"2026-01-29 06:44","pubTimestamp":1769640251,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260128:nFWN3YT1CL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7096","MYX.AU"],"gpt_icon":0},{"id":"2607729853","title":"Mayne Pharma Group Ltd - FY a$47M Underlying Ebitda","url":"https://stock-news.laohu8.com/highlight/detail?id=2607729853","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607729853?lang=en_us&edition=fundamental","pubTime":"2026-01-29 06:44","pubTimestamp":1769640251,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260128:nFWN3YT1CL:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","MYX.AU","BK7096"],"gpt_icon":0}],"pageSize":4,"totalPage":32,"pageCount":1,"totalSize":125,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/MYX.AU\",params:#limit:6,delay:true,,,undefined,":[{"market":"AU","name":"Pharmaceutical Companies","bkCode":"BK7508","id":"package_au_concept_yyswg","changeRate":-0.054913}]}}